ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Abbott already churns out a variety of catheters, stents, imaging systems and other technologies used to remove plaque buildups from blood vessels and keep the blood flowing through the newly cleaned ...

“During Q4, we achieved strong sequential growth across all business segments with our U.S. peripheral and coronary atherectomy franchises growing 9% and 16% over prior quarter, respectively.

Cellular biomechanics of neural and vascular injury, mechanotransduction in the cardiovascular system, mechanical control of growth and development for wound healing and tissue engineering Engineering ...

For decades, cardiology has been among the most advanced fields in medicine. We have strong evidence, effective medications and clear guidelines for preventing heart attacks and strokes. And yet, ...

“We are pleased with the state of our business and our performance in the first quarter. Q1 revenue of $59.7 million represented 2.2% revenue growth compared to last year. Worldwide coronary revenue ...